» Articles » PMID: 36402299

Role of Bile Acid Receptor FXR in Development and Function of Brown Adipose Tissue

Overview
Publisher Elsevier
Date 2022 Nov 19
PMID 36402299
Authors
Affiliations
Soon will be listed here.
Abstract

Bile acids act as signalling molecules that contribute to maintenance of energy homeostasis in mice and humans. Activation of G-protein-coupled bile acid receptor TGR5 induces energy expenditure in brown adipose tissue (BAT). However, a role for the nuclear bile acid receptor Farnesoid X receptor (FXR) in BAT has remained ambiguous. We aimed to study the potential role of FXR in BAT development and functioning. Here we demonstrate low yet detectable expression of the α1/2 isoforms of FXR in murine BAT that markedly decreases upon cold exposure. Moderate adipose tissue-specific FXR overexpression in mice induces pronounced BAT whitening, presenting with large intracellular lipid droplets and extracellular collagen deposition. Expression of thermogenic marker genes including the target of Tgr5, Dio2, was significantly lower in BAT of chow-fed aP2-hFXR mice compared to wild-type controls. Transcriptomic analysis revealed marked up-regulation of extracellular matrix formation and down-regulation of mitochondrial functions in BAT from aP2-hFXR mice. In addition, markers of cell type lineages deriving from the dermomyotome, such as myocytes, as well as markers of cellular senescence were strongly induced. The response to cold and β3-adrenergic receptor agonism was blunted in these mice, yet resolved BAT whitening. Newborn cholestatic Cyp2c70 mice with a human-like bile acid profile also showed distinct BAT whitening and upregulation of myocyte-specific genes, while thermogenic markers were down-regulated. Ucp1 expression inversely correlated with plasma bile acid levels. Therefore, bile acid signalling via FXR has a role in BAT function already early in tissue development. Functionally, FXR activation appears to oppose TGR5-mediated thermogenesis.

Citing Articles

Role of Bile Acid Receptors in the Development and Function of Diabetic Nephropathy.

Fang Y, Qin M, Zheng Q, Wang K, Han X, Yang Q Kidney Int Rep. 2024; 9(11):3116-3133.

PMID: 39534198 PMC: 11551060. DOI: 10.1016/j.ekir.2024.08.002.


Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases.

Wang Y, Xu H, Zhou X, Chen W, Zhou H Med Rev (2021). 2024; 4(4):262-283.

PMID: 39135605 PMC: 11317083. DOI: 10.1515/mr-2024-0020.


Chenodeoxycholic Acid-Loaded Nanoparticles Are Sufficient to Decrease Adipocyte Size by Inducing Mitochondrial Function.

Zhou W, Lew B, Choi H, Kim K, Anakk S Nano Lett. 2024; 24(5):1642-1649.

PMID: 38278518 PMC: 10854752. DOI: 10.1021/acs.nanolett.3c04352.


Bile Acid Network and Vascular Calcification-Associated Diseases: Unraveling the Intricate Connections and Therapeutic Potential.

Wang C, Ma Q, Yu X Clin Interv Aging. 2023; 18:1749-1767.

PMID: 37885621 PMC: 10599251. DOI: 10.2147/CIA.S431220.


FXR Friend-ChIPs in the Enterohepatic System.

Meadows V, Yang Z, Basaly V, Guo G Semin Liver Dis. 2023; 43(3):267-278.

PMID: 37442156 PMC: 10620036. DOI: 10.1055/a-2128-5538.